免疫腫瘤檢測市場：按適應症、按產品、按技術、按用途- 2023-2030 年全球預測

全球免疫腫瘤檢測市場預計將以 15.24%的年複合成長率成長，到 2023 年達到 62.6447 億美元，到 2030 年達到 169.3335 億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球免疫腫瘤檢測市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 免疫腫瘤學檢測的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球免疫腫瘤檢測市場的阻礙因素與影響有哪些？

3.在預測期內，全球免疫腫瘤檢測市場需要投資哪些產品/細分市場/應用/領域？

4. 全球免疫腫瘤檢測市場的競爭策略為何？

5. 全球免疫腫瘤檢測市場的技術趨勢和法律規範是什麼？

6.全球免疫腫瘤檢測市場主要供應商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球免疫腫瘤檢測市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 與其他治療方案相比，癌症發生率增加以及標靶治療的採用
    • 開發生物資訊學工具以增強藥物開發過程
    • 醫療費用和醫療保險的增加
  • 抑制因素
    • 不利的法規和報銷情況
  • 機會
    • 癌症治療技術與研發的進步
    • 伴隨診斷的出現
  • 任務
    • 缺乏操作設備的醫護人員
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 免疫腫瘤檢測市場（依適應症）

• 膀胱癌
• 大腸直腸癌
• 肺癌
• 黑色素瘤

第7章 免疫腫瘤檢測市場：副產品

• 消耗品
• 軟體

第8章 免疫腫瘤學檢測市場：依技術分類

• 流式細胞儀
• 檢測法
• 下一代定序
• 聚合酶鍊式反應

第9章 免疫腫瘤檢測市場：依用途

• 臨床診斷
• 調查

第10章 美洲免疫腫瘤檢測市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太免疫腫瘤檢測市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲免疫腫瘤檢測市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

• 討論指南
• 關於許可證和定價

The Global Immuno Oncology Assays Market is forecasted to grow significantly, with a projected USD 6,264.47 million in 2023 at a CAGR of 15.24% and expected to reach a staggering USD 16,933.35 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immuno Oncology Assays Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Immuno Oncology Assays Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Bladder Cancer, Colorectal Cancer, Lung Cancer, and Melanoma. The Melanoma is projected to witness significant market share during forecast period.

Based on Product, market is studied across Consumables and Software. The Consumables is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Flow Cytometry, Immunoassay, Next-Generation Sequencing, and Polymerase Chain Reaction. The Polymerase Chain Reaction is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical Diagnostics and Research. The Research is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Immuno Oncology Assays Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Immuno Oncology Assays Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immuno Oncology Assays Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immuno Oncology Assays Market?

4. What is the competitive strategic window for opportunities in the Global Immuno Oncology Assays Market?

5. What are the technology trends and regulatory frameworks in the Global Immuno Oncology Assays Market?

6. What is the market share of the leading vendors in the Global Immuno Oncology Assays Market?

7. What modes and strategic moves are considered suitable for entering the Global Immuno Oncology Assays Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Immuno Oncology Assays Market, by Indication, 2022 vs 2030
• 4.3. Immuno Oncology Assays Market, by Product, 2022 vs 2030
• 4.4. Immuno Oncology Assays Market, by Technology, 2022 vs 2030
• 4.5. Immuno Oncology Assays Market, by Application, 2022 vs 2030
• 4.6. Immuno Oncology Assays Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of cancer and adoption of targeted therapy over other treatment options
    • 5.1.1.2. Development of bioinformatic tools enhancing the drug development process
    • 5.1.1.3. Rise in healthcare expenditure and healthcare insurance
  • 5.1.2. Restraints
    • 5.1.2.1. Unfavorable regulatory and reimbursement scenario
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement and R&D for the treatment of cancer
    • 5.1.3.2. Emergence of companion diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of healthcare professions for device operation
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Immuno Oncology Assays Market, by Indication

• 6.1. Introduction
• 6.2. Bladder Cancer
• 6.3. Colorectal Cancer
• 6.4. Lung Cancer
• 6.5. Melanoma

7. Immuno Oncology Assays Market, by Product

• 7.1. Introduction
• 7.2. Consumables
• 7.3. Software

8. Immuno Oncology Assays Market, by Technology

• 8.1. Introduction
• 8.2. Flow Cytometry
• 8.3. Immunoassay
• 8.4. Next-Generation Sequencing
• 8.5. Polymerase Chain Reaction

9. Immuno Oncology Assays Market, by Application

• 9.1. Introduction
• 9.2. Clinical Diagnostics
• 9.3. Research

10. Americas Immuno Oncology Assays Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Immuno Oncology Assays Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Immuno Oncology Assays Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. IMMUNO ONCOLOGY ASSAYS MARKET RESEARCH PROCESS
• FIGURE 2. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2022 VS 2030
• FIGURE 3. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 5. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 6. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 7. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. IMMUNO ONCOLOGY ASSAYS MARKET DYNAMICS
• FIGURE 10. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. IMMUNO ONCOLOGY ASSAYS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 5. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 10. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 13. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT-GENERATION SEQUENCING , BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 189. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 190. IMMUNO ONCOLOGY ASSAYS MARKET LICENSE & PRICING